SLCO1B1 and rhabdomyolysis: In an analysis by Marciante et al., a candidate gene study (examining CYP2C8, UGT1A1, UGT1A3, and SLCO1B1) and a GWAS study were performed on 185 cerivastatin-induced rhabdomyolysis cases matched to statin-using controls from Cardiovascular Health Study (n = 374) and Vascular Health Study (n = 358) [70], A subsequent in vitro functional analysis for 521T>C was also performed in stable HEK293 cells.